Next-generation sequencing (NGS) has enabled new approaches for detection of mutations in the BRCA1 and BRCA2 genes responsible for hereditary breast and ovarian cancer (HBOC). Here, BRCA1 is linked to Hereditary breast and ovarian cancer syndrome.